Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Non-segmental Vitiligo: full-pipeline trial registry
5 of 10 indexed Non-segmental Vitiligo trials are currently recruiting.
Corpus placement: #1,724 of 28,707 conditions by registered trial count.
10 US clinical trials · 5 currently recruiting · #1,724 of 28,707 conditions by registered trial count
Non-segmental Vitiligo: 10 US clinical trials tracked, 5 recruiting.
Non-segmental Vitiligo is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most active sponsor is Incyte Corporation, running 4 of these trials.
Enrollment posture brief
Registry condition non-segmental-vitiligo
OPEN 5 | RECR 50% | LATE 4 | EARLY 6 | RANK #1724 | SPON 4
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Non-segmental Vitiligo lists 5 open slots (50% of 10 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Non-segmental Vitiligo on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Non-segmental Vitiligo is recruiting above its size-band peers.
5 of 10 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Non-segmental Vitiligo research.
Incyte Corporation accounts for 4 of 10 trials (40%). 7 distinct sponsors appear on at least one study for this condition label.
-
Typical Non-segmental Vitiligo enrolment sits around 210 participants.
Median target enrolment is 210 among the 10 trials that report a genuine target (sentinel values excluded). 2 of those (20%) plan for fewer than 100 participants.
-
Non-segmental Vitiligo research is mostly interventional.
10 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
10 total, page 1 of 1
A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
Novartis Pharmaceuticals
NCT07431177
A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
Takeda
NCT07108283
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
Incyte Corporation
NCT06548360
Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients
Elixiron Immunotherapeutics (Hong Kong)
NCT07223229
An Open-label Single Center, Proof of Concept Study Evaluating the Efficacy of Roflumilast Foam 0.3% in Pediatric Patients With Non-Segmental Vitiligo (NSV)
Derm Texas, P
NCT07105254
A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1)
Incyte Corporation
NCT06113445
A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2)
Incyte Corporation
NCT06113471
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo.
Vyne Therapeutics
NCT06493578
Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1)
Incyte Corporation
NCT04052425
Efficacy and Safety of AS012 in Subjects With Non-segmental Vitiligo
Ache Laboratorios Farmaceuticos S.A.
NCT04487860
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 6 |
| Phase 3 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Non-segmental Vitiligo records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Non-segmental Vitiligo trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Non-segmental Vitiligo page
10 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Non-segmental Vitiligo trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Incyte Corporation sponsors the most Non-segmental Vitiligo trials on record, review their full trial history before evaluating a specific study. See Incyte Corporation's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Non-segmental Vitiligo condition card totals 10 registered trials; most-linked intervention Placebo; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.